Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2023-01-11 Sale | 2023-01-13 4:34 pm | Applied Therapeutics Inc. | APLT | Shendelman Shoshana President and CEO 10% Owner | 15,870 | $0.91 | $14,442 | 7,046,478 (Indirect Direct) | View |
2023-01-11 Sale | 2023-01-13 4:32 pm | Applied Therapeutics Inc. | APLT | Perfetti Riccardo Chief Medical Officer | 6,053 | $0.91 | $5,508 | 704,856 (Direct) | View |
2023-01-11 Sale | 2023-01-13 4:30 pm | Applied Therapeutics Inc. | APLT | Hansard Adam Chief Commercial Officer | 4,495 | $0.91 | $4,090 | 392,475 (Direct) | View |
2022-10-14 Purchase | 2022-10-14 5:41 pm | Applied Therapeutics Inc. | APLT | Shendelman Shoshana President and CEO 10% Owner | 50,000 | $0.645 | $32,250 | 5,097,986 (Indirect Direct) | View |
2022-10-13 Purchase | 2022-10-13 6:17 pm | Applied Therapeutics Inc. | APLT | Shendelman Shoshana President and CEO 10% Owner | 73,256 | $0.5582 | $40,891 | 5,047,986 (Indirect Direct) | View |
2022-10-12 Purchase | 2022-10-12 8:51 pm | Applied Therapeutics Inc. | APLT | Shendelman Shoshana President and CEO 10% Owner | 38,153 | $0.5227 | $19,943 | 4,974,730 (Indirect Direct) | View |
2022-06-27 Purchase | 2022-06-29 4:37 pm | Applied Therapeutics Inc. | APLT | ALEXANDRIA REAL ESTATE EQUITIES INC. Alexandria Venture Investments LLC Alexandria Equities No. 7 LLC 10% Owner | 3,500,000 | $1 | $3,500,000 | 11,055,077 (Indirect) | View |
2022-05-16 Sale | 2022-05-18 9:03 pm | Applied Therapeutics Inc. | APLT | Mahadevan Chids See Remarks | 905 | $1.65 | $1,493 | 9,800 (Direct) | View |
2022-03-21 Purchase | 2022-03-23 9:00 pm | Applied Therapeutics Inc. | APLT | Perfetti Riccardo Chief Medical Officer | 64,509 | $1.9501 | $125,797 | 160,909 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2023-09-15 Exercise | 2023-09-19 8:08 pm | N/A 2032-06-02 | Applied Therapeutics Inc. | APLT | MARCUS JOEL S Director | 12,375 | $0 | 453,414 (Direct) | View |
2023-09-15 Exercise | 2023-09-19 8:08 pm | N/A N/A | Applied Therapeutics Inc. | APLT | MARCUS JOEL S Director | 12,375 | $1.05 | 453,414 (Direct) | View |
2023-06-06 Option Award | 2023-06-08 9:03 pm | N/A N/A | Applied Therapeutics Inc. | APLT | SKYLER JAY S Director | 20,000 | $0 | 20,000 (Direct) | View |
2023-06-06 Option Award | 2023-06-08 9:03 pm | N/A N/A | Applied Therapeutics Inc. | APLT | MARCUS JOEL S Director | 20,000 | $0 | 441,039 (Direct) | View |
2023-06-06 Option Award | 2023-06-08 9:02 pm | N/A N/A | Applied Therapeutics Inc. | APLT | Lerner Teena Director | 20,000 | $0 | 60,422 (Direct) | View |
2023-06-06 Option Award | 2023-06-08 9:02 pm | N/A N/A | Applied Therapeutics Inc. | APLT | Kanter Stacy J. Director | 20,000 | $0 | 33,000 (Direct) | View |
2023-06-06 Option Award | 2023-06-08 9:01 pm | N/A N/A | Applied Therapeutics Inc. | APLT | Funtleyder Leslie D. Director | 20,000 | $0 | 37,148 (Direct) | View |
2023-01-11 Option Award | 2023-01-13 4:34 pm | N/A N/A | Applied Therapeutics Inc. | APLT | Shendelman Shoshana President and CEO 10% Owner | 1,964,362 | $0 | 7,046,478 (Direct) | View |
2023-01-11 Option Award | 2023-01-13 4:32 pm | N/A N/A | Applied Therapeutics Inc. | APLT | Perfetti Riccardo Chief Medical Officer | 550,000 | $0 | 704,856 (Direct) | View |
2023-01-11 Option Award | 2023-01-13 4:30 pm | N/A N/A | Applied Therapeutics Inc. | APLT | Hansard Adam Chief Commercial Officer | 300,000 | $0 | 392,475 (Direct) | View |
2022-11-15 Option Award | 2022-11-17 9:31 pm | N/A N/A | Applied Therapeutics Inc. | APLT | Ortega Steven A. Principal Accounting Officer | 40,000 | $0 | 55,404 (Direct) | View |
2021-04-14 Exercise(A) | 2022-09-16 9:02 pm | N/A N/A | Applied Therapeutics Inc. | APLT | MARCUS JOEL S Director | 35,911 | $4.7 | 74,824 (Indirect) | View |
2021-04-14 Exercise(A) | 2022-09-16 9:02 pm | N/A N/A | Applied Therapeutics Inc. | APLT | MARCUS JOEL S Director | 13,071 | $10 | 74,824 (Indirect) | View |
2021-04-14 Exercise(A) | 2022-09-16 9:02 pm | N/A 2029-05-12 | Applied Therapeutics Inc. | APLT | MARCUS JOEL S Director | 13,071 | $0 | 74,824 (Direct) | View |
2022-09-14 Exercise | 2022-09-16 9:01 pm | N/A 2029-05-12 | Applied Therapeutics Inc. | APLT | MARCUS JOEL S Director | 38,244 | $0 | 433,414 (Direct) | View |
2022-09-14 Exercise | 2022-09-16 9:01 pm | N/A N/A | Applied Therapeutics Inc. | APLT | MARCUS JOEL S Director | 38,244 | $1.05 | 433,414 (Direct) | View |
2022-08-02 Disposition | 2022-08-04 8:41 pm | N/A 2032-06-02 | Applied Therapeutics Inc. | APLT | SKYLER JAY S Director | 127,380 | $0 | 63,690 (Direct) | View |
2022-08-02 Disposition | 2022-08-04 8:40 pm | N/A 2032-01-25 | Applied Therapeutics Inc. | APLT | Shendelman Shoshana President and CEO 10% Owner | 2,204,132 | $0 | 1,102,066 (Direct) | View |
2022-08-02 Disposition | 2022-08-04 8:39 pm | N/A 2032-04-13 | Applied Therapeutics Inc. | APLT | Perfetti Riccardo Chief Medical Officer | 674,716 | $0 | 337,358 (Direct) | View |
2022-08-02 Disposition | 2022-08-04 8:39 pm | N/A 2032-06-02 | Applied Therapeutics Inc. | APLT | MARCUS JOEL S Director | 101,238 | $0 | 50,619 (Direct) | View |
2022-08-02 Disposition | 2022-08-04 8:38 pm | N/A 2032-04-13 | Applied Therapeutics Inc. | APLT | Mahadevan Chids See Remarks | 70,292 | $0 | 35,146 (Direct) | View |
2022-08-02 Disposition | 2022-08-04 8:37 pm | N/A 2032-06-02 | Applied Therapeutics Inc. | APLT | Lerner Teena Director | 127,380 | $0 | 63,690 (Direct) | View |
2022-08-02 Disposition | 2022-08-04 8:36 pm | N/A 2032-06-02 | Applied Therapeutics Inc. | APLT | Kanter Stacy J. Director | 127,380 | $0 | 63,690 (Direct) | View |
2022-08-02 Disposition | 2022-08-04 8:35 pm | N/A 2032-04-13 | Applied Therapeutics Inc. | APLT | Hansard Adam Chief Commercial Officer | 458,408 | $0 | 229,204 (Direct) | View |
2022-08-02 Disposition | 2022-08-04 8:35 pm | N/A 2032-06-02 | Applied Therapeutics Inc. | APLT | Funtleyder Leslie D. Director | 127,380 | $0 | 63,690 (Direct) | View |
2022-06-03 Option Award | 2022-06-07 9:21 pm | N/A 2032-06-02 | Applied Therapeutics Inc. | APLT | SKYLER JAY S Director | 16,500 | $0 | 16,500 (Direct) | View |
2022-06-03 Option Award | 2022-06-07 9:21 pm | N/A 2032-06-02 | Applied Therapeutics Inc. | APLT | MARCUS JOEL S Director | 16,500 | $0 | 16,500 (Direct) | View |
2022-06-03 Option Award | 2022-06-07 9:20 pm | N/A 2032-06-02 | Applied Therapeutics Inc. | APLT | Lerner Teena Director | 16,500 | $0 | 16,500 (Direct) | View |
2022-06-03 Option Award | 2022-06-07 9:20 pm | N/A 2032-06-02 | Applied Therapeutics Inc. | APLT | Kanter Stacy J. Director | 16,500 | $0 | 16,500 (Direct) | View |
2022-06-03 Option Award | 2022-06-07 9:19 pm | N/A 2032-06-02 | Applied Therapeutics Inc. | APLT | Funtleyder Leslie D. Director | 16,500 | $0 | 16,500 (Direct) | View |
2022-04-13 Option Award | 2022-04-15 7:10 pm | N/A 2032-04-13 | Applied Therapeutics Inc. | APLT | Perfetti Riccardo Chief Medical Officer | 50,000 | $0 | 50,000 (Direct) | View |
2022-04-13 Option Award | 2022-04-15 7:09 pm | N/A 2032-04-13 | Applied Therapeutics Inc. | APLT | Ortega Steven A. Principal Accounting Officer | 13,756 | $0 | 26,079 (Direct) | View |
2022-04-13 Option Award | 2022-04-15 7:08 pm | N/A 2032-04-13 | Applied Therapeutics Inc. | APLT | Mahadevan Chids See Remarks | 21,194 | $0 | 29,763 (Direct) | View |
2022-04-13 Option Award | 2022-04-15 7:07 pm | N/A 2032-04-13 | Applied Therapeutics Inc. | APLT | Hansard Adam Chief Commercial Officer | 50,000 | $0 | 50,000 (Direct) | View |
Ownership | 2022-03-18 4:34 pm | N/A N/A | Applied Therapeutics Inc. | APLT | Ortega Steven A. Principal Accounting Officer | 0 | $0 | 32,030 (Direct) | View |
2022-02-23 Other | 2022-02-25 4:52 pm | N/A N/A | Applied Therapeutics Inc. | APLT | ALEXANDRIA REAL ESTATE EQUITIES INC. Alexandria Venture Investments LLC Alexandria Equities No. 7 LLC 10% Owner | 300,000 | $0 | 1,543,977 (Indirect) | View |
2022-01-25 Option Award | 2022-01-27 6:32 pm | N/A 2032-01-25 | Applied Therapeutics Inc. | APLT | Shendelman Shoshana President and CEO 10% Owner | 234,616 | $0 | 234,616 (Direct) | View |